https://vimeo.com/1237781386?share=copy&fl=cl&fe=ci In this special Zinzino science presentation, Dr. Natalie Kather and Stephen Cherniske explore the findings of a major new peer-reviewed research paper, Real-world omega-3 supplementation patterns and whole-blood fatty-acid biomarkers: a cross-sectional analysis of 762,150 dried blood spot samples, published in Lipids in Health and Disease on 15 October 2026. The study examines more than 762,000 real-world blood samples, comparing fatty-acid biomarkers across people who reported taking no omega-3 supplements, people supplementing independently, and people participating in a structured omega-3 programme. The findings raise an important question: If you're taking omega-3 supplements, how do you know they're actually improving your omega-3 status? Natalie and Stephen explain the science behind the research, why measuring more than one fatty-acid marker matters, and how a structured approach involving personalised dosing, consistent supplementation and follow-up testing is associated with more favourable biomarker patterns. They also share practical ways Zinzino partners can communicate the findings, educate customers and introduce the value of test-based nutrition through clear, evidence-informed conversations. In This Presentation You'll Learn: ✅ Why this new research involving 762,150 dried blood spot samples is significant ✅ How the study builds on earlier research involving more than 500,000 blood samples ✅ The differences between non-users, independent omega-3 supplement users and structured programme participants ✅ Why taking omega-3 supplements does not automatically mean you have optimal fatty-acid levels ✅ How whole-blood EPA and DHA levels differed across the three groups ✅ What the arachidonic acid-to-EPA (AA/EPA) ratio reveals about fatty-acid balance ✅ Why EPA + DHA and AA/EPA provide complementary information rather than interchangeable measurements